Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality in motion Quality Strong, Valuation Fairly Valued, Momentum Bullish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #75 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 31 May 2022 | PAWAN CHAUDHARY | Promoter | Buy | 0 | ₹0 |
| 4 Jun 2021 | MANU CHAUDHARY | Promoter | Buy | 0 | ₹0 |
| 4 Jun 2021 | PAWAN CHAUDHARY | Promoter | Buy | 0 | ₹0 |
| 25 Feb 2021 | MANU CHAUDHARY | Promoter | Buy | 0 | ₹0 |
| 25 Feb 2021 | PAWAN CHAUDHARY | Promoter | Buy | 0 | ₹0 |
| 8 Jun 2017 | MANU CHAUDHARY | Promoter | Buy | 0 | ₹0 |
| 8 Jun 2017 | PAWAN CHAUDHARY | Promoter | Buy | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 30 May 2025 | PRADEEP KUMAR JAIN | Bulk | Sell | 135,966 | 422.7700 | NSE |
| 6 Feb 2025 | PARTH INFIN BROKERS PVT LTD | Bulk | Buy | 125,195 | 354.8300 | NSE |
| 6 Feb 2025 | PARTH INFIN BROKERS PVT LTD | Bulk | Sell | 114,490 | 353.8800 | NSE |
| 6 Feb 2025 | CRONY VYAPAR PVT LTD | Bulk | Buy | 75,190 | 356.9100 | NSE |
| 6 Feb 2025 | CRONY VYAPAR PVT LTD | Bulk | Sell | 50,190 | 352.6000 | NSE |
| 11 Apr 2023 | YUGA STOCKS AND COMMODITIES PRIVATE LIMITED . | Bulk | Sell | 73,165 | 203.6100 | NSE |
| 11 Apr 2023 | YUGA STOCKS AND COMMODITIES PRIVATE LIMITED . | Bulk | Buy | 73,165 | 201.2700 | NSE |
| 31 May 2022 | PAWAN CHAUDHARY | Bulk | Buy | 84,246 | 221.9500 | NSE |
| 12 May 2022 | GUTTIKONDA RAJASEKHAR | Bulk | Sell | 69,399 | 211.4600 | NSE |
| 27 Oct 2021 | XTX MARKETS LLP | Bulk | Sell | 69,468 | 561.8900 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 7 Aug 2026 | Dividend - Rs 10 Per Share | 10.0000 | 7 Aug 2026 |
| 23 Sep 2013 | Annual General Meeting / Dividend - Rs 3/- Per Share | 3.0000 | — |
| 20 Sep 2012 | Annual General Meeting / Dividend Rs. 3/- Per Share | 3.0000 | — |
| 22 Sep 2011 | Annual General Meeting And Dividend Rs.3/- Per Share | 3.0000 | — |
| 23 Sep 2010 | Annual General Meeting And Dividend Rs.3/- Per Share | 3.0000 | — |
| 12 Sep 2008 | Agm/Dividend - 40% | — | — |
| 18 Sep 2007 | Agm/Dividend-30% | — | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 13 Sep 2024 | OTHER | Annual General Meeting |
| 17 Aug 2023 | OTHER | Annual General Meeting |
| 11 Aug 2022 | OTHER | Annual General Meeting |
| 9 Sep 2021 | OTHER | Annual General Meeting |
| 24 Nov 2020 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 20 Jul 2026 | Financial Results/Other business matters | Yes |
| 26 May 2026 | Financial Results/Dividend | Yes |
| 29 Jan 2026 | Financial Results | Yes |
| 19 Jan 2026 | Financial Results | Yes |
| 10 Nov 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 30 Sep 2026 | Company Update | Venus Remedies Ltd - 526953 - Intimation For Change In Company Identification Number (CIN). |
| 30 Sep 2026 | Updates | Venus Remedies Limited has informed the Exchange regarding 'Intimation regarding change in Corporate Identification Number (CIN).'. |
| 25 Sep 2026 | Trading Window | Venus Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 25 Sep 2026 | Insider Trading / SAST | Venus Remedies Ltd - 526953 - Closure of Trading Window |
| 10 Sep 2026 | Company Update | Venus Remedies Ltd - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 10 Sep 2026 | Copy of Newspaper Publication | Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication |
| 9 Sep 2026 | Company Update | Venus Remedies Ltd - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 9 Sep 2026 | Copy of Newspaper Publication | Venus Remedies Limited has informed the Exchange about newspaper publication of notice to physical shareholders for transfer of physical shares as per SEBI circular. |
| 8 Sep 2026 | Company Update | Venus Remedies Ltd - 526953 - Social Media Post On Shareholders Awareness On Transfer Of Physical Shares. |
| 7 Sep 2026 | Updates | Venus Remedies Limited has informed the Exchange regarding Social Media Post on awareness on transfer of physical shares ''. |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
